Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: Effect on hypertension and ESRD

Yonsei Medical Journal

Volumn 44, Issue 4, 2003, Pages 641-647

  Lee, Kyu Beck ^a   Kim, Un Kyung ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

Angiotensin; Angiotensinogen; Autosomal dominant; Polycystic kidney; Polymorphism

Indexed keywords

ADENINE; ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; CYTOSINE; METHIONINE; RENIN; THREONINE;

ADULT; AGE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; HYPOTHESIS; KIDNEY FAILURE; KIDNEY ISCHEMIA; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTRICTION MAPPING;

EID: 0041879912     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2003.44.4.641     Document Type: Article

References (27)

1. Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT. Epidemiology of adult polycystic kidney disease, Olmsted County, Minessota 1935-1980. Am J Kidney Dis 1983;2:630-9.
2. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 1993;329:332-42.
3. Johnson AM, Gabow PA. Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol 1997;8:1560-7.
4. Milutinovic J, Rust PF, Fialkow PJ, Agodoa LY, Phillips LA, Rudd TG, et al. Intrafamilial phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis 1992;115:465-7.
5. Levy M, Duyme M, Serbelloni P, Conte F, Sessa A, Grunfeld JP. Is progression of renal involvement similar in twins with ADPKD? A multicentric European study. Contrib Nephrol 1995;115:65-71.
6. Woo DD, Nguyen DK, Khatibi N, Olsen P. Genetic identification of two major modifier loci of polycystic kidney disease progression in pcy mice. J Clin Invest 1997;100:1934-40.
7. Chapman AB, Johnson A, Gabow PA, Schrier RW. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 1990;323:1091-6.
8. Torres VE, Donovan KA, Scicli G, Holley KE, Thibodeau SN, Carretero OA, et al. Synthesis of rennin by tubulocystic epithelium in autosomal dominant polycystic kidney disease. Kidney Int 1992;42:364-73.
9. Schmidt S, Ritz E. Genetics of the renin-angiotensin system and renal disease: a progress report. Curr Opin Nephrol Hypertens 1997;6:146-51.
10. Rothermund L, Paul M. Hypertension and the rennin-angiotensin system: evidence from genetic and transgenic studies. Basic Res Cardiol 1998;93:S1-6.
11. Duncan JA, Scholey JW, Miller JA. Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens 2001;10:111-6.
12. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-80.
13. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, et al. Angiotensin II type 1 receptor gene polymorphisms, in human essential hypertension. Hypertension 1994;24:63-9.
14. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994;343:824-7.
15. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
16. Russ AP, Maerz W, Ruzicka V, Stein U, Grob W. Rapid detection of the hypertension-associated Met235 Thr allele of the human angiotensiongen gene. Hum Mol Genet 1993;2:609-10.
17. Hingorani AD, Brown MJ. A simple molecular assay for the C1166 variant of the angiotensin II type 1 receptor gene. Biochem Biophys Res Commun 1995;213: 725-9.
18. Johnson AM, Gabow PA. Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end stage renal disease. J Am Soc Nephrol 1997;8:1560-7.
19. Kunz R, Kreutz R, Beige J, Distler A, Sharma AM. Association between the angiotensinogen 235T-variant and essential hypertension in whites. Hypertension 1997;30:1331-7.
20. Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999;17:9-17.
21. Baboolal K, Ravine D, Daniels J, Williams N, Holmans P, Coles GA, et al. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int 1997;52:607-13.
22. Perez-Oller L, Torra R, Badenas C, Mila M, Darnell A. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1999;34:273-8.
23. Konoshita T, Miyagi K, Onoe T, Katano K, Mutoh H, Nomura H, et al. Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan. Am J Kidney Dis 2001;37:113-8.
24. Bennett CL, Schrader AP, Morris BJ. Cross-Sectional analysis of Met253- the variant of angiotensinogen gene in severe familial hypertension. Biochem Biophys Res Commun 1993;197:833-9.
25. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994;93:1285-7.
26. Niu T, Yang J, Wang B, Chen W, Wang Z, Laird N, et al. Angiotensinogen gene polymorphism M235T/ T147M; No excess transmission to hypertensive Chinese. Hypertension 1999;33:687-702.
27. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994;24:63-9.